ETS gene fusions in prostate cancer: from discovery to daily clinical practice

SA Tomlins, A Bjartell, AM Chinnaiyan, G Jenster… - European urology, 2009 - Elsevier
CONTEXT: In 2005, fusions between the androgen-regulated transmembrane protease
serine 2 gene, TMPRSS2, and E twenty-six (ETS) transcription factors were discovered in …

[HTML][HTML] Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) …

S Gillessen, A Omlin, G Attard, JS De Bono… - Annals of …, 2015 - Elsevier
The first St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert
Panel identified and reviewed the available evidence for the ten most important areas of …

The use of PCA3 in the diagnosis of prostate cancer

D Hessels, JA Schalken - Nature Reviews Urology, 2009 - nature.com
Although the routine use of serum PSA testing has undoubtedly increased prostate cancer
detection, one of its main drawbacks has been its lack of specificity, which results in a high …

DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer

D Hessels, JMTK Gunnewiek, I van Oort… - European urology, 2003 - Elsevier
Background: DD3 PCA3 is the most prostate cancer-specific gene described to date. To
assess the clinical utility of DD3 PCA3 a time-resolved fluorescence-based, quantitative RT-…

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer

R Umbas, JA Schalken, TW Aalders, BS Carter… - Cancer research, 1992 - AACR
E-cadherin is a Ca 2+ -dependent cell adhesion molecule which plays an important role in
normal growth and development via mediation of homotypic, homophilic cell-cell interaction. …

Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer

D Hessels, FP Smit, GW Verhaegh, JA Witjes… - Clinical Cancer …, 2007 - AACR
Purpose: Early detection of prostate cancer can increase the curative success rate for prostate
cancer. We studied the diagnostic usefulness of TMPRSS2-ERG fusion transcripts as well …

DD3::A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer

MJG Bussemakers, A Van Bokhoven, GW Verhaegh… - Cancer research, 1999 - AACR
Schalken JA New perspectives in the treatment of prostate cancer. … Bussemakers MJG, Van
de Ven WJM, Debruyne FMJ, Schalken JA Identification of high mobility group protein I(Y) as …

DD3 PCA3 , a Very Sensitive and Specific Marker to Detect Prostate Tumors

JB De Kok, GW Verhaegh, RW Roelofs, D Hessels… - Cancer research, 2002 - AACR
We identified DD3 PCA3 as one of the most prostate cancer-specific genes at present (MJ
Bussemakers et al. Cancer Res., 59: 5975–5979, 1999). Consequently, DD3 PCA3 is an …

Cadherin switching in human prostate cancer progression

K Tomita, A van Bokhoven, GJLH van Leenders… - Cancer research, 2000 - AACR
… Bringuier PP, Umbas R., Schaafsma HE, Karthaus HF, Debruyne FM, Schalken JA Decreased
E-… Bussemakers MJG, Van Bokhoven A., Tomita K., Jansen CFJ, Schalken JA Cadherin …

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types

T Rafnar, P Sulem, SN Stacey, F Geller… - Nature …, 2009 - nature.com
The common sequence variants that have recently been associated with cancer risk are
particular to a single cancer type or at most two. Following up on our genome-wide scan of …